PUBLICATION

A defined clathrin-mediated trafficking pathway regulates sFLT1/VEGFR1 secretion from endothelial cells

Authors
Kinghorn, K., Gill, A., Marvin, A., Li, R., Quigley, K., Singh, S., Gore, M.T., le Noble, F., Gabhann, F.M., Bautch, V.L.
ID
ZDB-PUB-230912-54
Date
2023
Source
Angiogenesis   27(1): 67-89 (Journal)
Registered Authors
Bautch, Victoria, Gore, Michaelanthony, le Noble, Ferdinand
Keywords
AP1, Clathrin, Golgi, Secretion, sFLT1, vWF
MeSH Terms
  • Animals
  • Clathrin/metabolism
  • Endothelial Cells*/metabolism
  • Vascular Endothelial Growth Factor Receptor-1*/metabolism
  • Zebrafish/metabolism
PubMed
37695358 Full text @ Angiogenesis
Abstract
FLT1/VEGFR1 negatively regulates VEGF-A signaling and is required for proper vessel morphogenesis during vascular development and vessel homeostasis. Although a soluble isoform, sFLT1, is often mis-regulated in disease and aging, how sFLT1 is trafficked and secreted from endothelial cells is not well understood. Here we define requirements for constitutive sFLT1 trafficking and secretion in endothelial cells from the Golgi to the plasma membrane, and we show that sFLT1 secretion requires clathrin at or near the Golgi. Perturbations that affect sFLT1 trafficking blunted endothelial cell secretion and promoted intracellular mis-localization in cells and zebrafish embryos. siRNA-mediated depletion of specific trafficking components revealed requirements for RAB27A, VAMP3, and STX3 for post-Golgi vesicle trafficking and sFLT1 secretion, while STX6, ARF1, and AP1 were required at the Golgi. Live-imaging of temporally controlled sFLT1 release from the endoplasmic reticulum showed clathrin-dependent sFLT1 trafficking at the Golgi into secretory vesicles that then trafficked to the plasma membrane. Depletion of STX6 altered vessel sprouting in 3D, suggesting that endothelial cell sFLT1 secretion influences proper vessel sprouting. Thus, specific trafficking components provide a secretory path from the Golgi to the plasma membrane for sFLT1 in endothelial cells that utilizes a specialized clathrin-dependent intermediate, suggesting novel therapeutic targets.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping